晨间信号Morning Signal
《科学》 第391卷 第6790期 · 2026年3月12日 · 中文解读

经典癌基因的拓展:Src在癌细胞表面的暴露与治疗靶向

Extending the reach of a classic oncogene · A. Pfannenstein and T. Meyer
约 5 分钟Perspectives在小程序里点播,20 到 60 分钟做好
这篇讲什么
本文报道了癌细胞通过自噬溶酶体胞吐将Src激酶递送至细胞表面,并展示了针对细胞外Src的免疫治疗在临床前模型中的有效性。
原文开头
Exocytosis exposes Src at the outer surface of cancer cells, poised for therapeutic targeting Alexander Pfannenstein and Tobias Meyer T he cellular kinase Src (or c-Src) plays a role in adhesion, motility, and proliferation. In cancers, its expression and activity are commonly increased, underscoring its pivotal role in sustaining malignant phenotypes across tumor types (1). On page 1124 of this issue, Delaveris et al. (2) report that many cancer cells with high Src expression also produce extracellular Src (e-Src) that is delivered to the extracellular-facing cell surface. Moreover, this exposed e-Src was effectively targeted by immunotherapy in preclinical tumor models. …
摘自《科学》(Science)第391卷 第6790期 · 2026年3月12日,A. Pfannenstein and T. Meyer。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。
晨间信号小程序码
微信扫码,在小程序里听完整版
不用登录先听一篇 · 或在微信搜索小程序 晨间信号
同期其他文章